Armistice Capital, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History

Armistice Capital, LLC

$5.71 Billion
Q2 2025

A detailed history of Armistice Capital, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,692,000 shares of RVPH stock, worth $1.21 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,692,000

Holding current value

$1.21 Million

% of portfolio

0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.34 - $1.12 $915,280 - $3.02 Million	2,692,000 New	2,692,000 $1.02 Million
Q4 2024 Feb 14, 2025	SELL	$0.92 - $2.82 $1.68 Million - $5.14 Million	-1,822,000 Reduced 57.19%	1,364,000 $2.36 Million
Q3 2024 Nov 14, 2024	BUY	$0.64 - $1.48 $2.04 Million - $4.72 Million	3,186,000 New	3,186,000 $4.59 Million
Q4 2023 Feb 13, 2024	BUY	$3.56 - $6.04 $4.14 Million - $7.03 Million	1,164,000 Added 194.0%	1,764,000 $9.08 Million
Q3 2023 Nov 14, 2023	SELL	$3.91 - $5.9 $875,840 - $1.32 Million	-224,000 Reduced 27.18%	600,000 $2.93 Million
Q2 2023 Aug 14, 2023	BUY	$4.42 - $8.55 $3.64 Million - $7.05 Million	824,000 New	824,000 $4.83 Million
Q1 2022 May 16, 2022	SELL	$1.61 - $3.01 $1.14 Million - $2.13 Million	-707,578 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.23 $207,570 - $325,193	76,878 Added 12.19%	707,578 $2.05 Million
Q3 2021 Nov 15, 2021	SELL	$3.29 - $4.79 $276,360 - $402,360	-84,000 Reduced 11.75%	630,700 $2.57 Million
Q2 2021 Aug 16, 2021	BUY	$4.05 - $8.7 $2.89 Million - $6.22 Million	714,700 New	714,700 $3.47 Million

Others Institutions Holding RVPH

# of Institutions

Shares Held

14.5M

Call Options Held

4.9M

Put Options Held

29.7K

View Full List

About REVIVA PHARMACEUTICALS HOLDINGS, INC.

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $9.2M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

More about RVPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History